OurCrowd

OurCrowd, established in 2013, is a global venture investing platform headquartered in Israel. It specializes in connecting accredited investors with curated, high-quality early-stage companies across various sectors, including healthcare, technology, energy, and transportation. OurCrowd invests in and supports its portfolio companies throughout their lifecycle, providing mentorship, industry connections, and follow-on funding opportunities. It is the most active venture investor in Israel and has a strong presence in the United States and other global markets.

Denes Ban

Managing Director

Dean Berger

Principal, Funds

Wolf Bielas

Venture Partner

Guy Dassa

Principal and Head of Co-Investments

Allen Kamer

Managing Partner

Etai Kramer

Managing Director, Head Funds

Jonathan Medved

Founder, CEO

Eli Nir

Senior Investment Partner

Moshe Raines

Partner

Liat Sverdlov

Investment Partner

Josh Hersch

Investor Director

Past deals in Computer Vision

Hailo

Series C in 2024
Hailo Technologies Ltd. specializes in developing advanced AI processors that facilitate deep learning applications on edge devices. Founded in 2017 and based in Tel Aviv, Israel, the company has created products such as the Hailo-8 and Hail SDK, which allow devices to perform complex tasks like object detection, image enhancement, and real-time content creation while minimizing power consumption and cost. Hailo's processors are designed to integrate seamlessly into a wide range of smart devices, including those used in automotive, security, personal computing, and industrial automation sectors. By rethinking traditional computer architecture, Hailo enables edge devices to process data locally, enhancing their capabilities and operational efficiency.

NeuReality

Venture Round in 2024
NeuReality is a semiconductor start-up focused on creating AI-as-a-service infrastructure to meet the demands of AI deployment across cloud, edge, and fog systems. The company specializes in purpose-built AI-centric architecture, offering a server-on-chip solution that reconfigures inference technologies like computer vision, natural language processing, and recommendation engines. This innovative approach simplifies the implementation of these technologies for companies that may lack extensive technical expertise. By replacing traditional CPU-centric models with its advanced architecture, NeuReality enables clients to reduce both costs and energy consumption, making AI more accessible and efficient for a broader range of users.

blackshark.ai

Series A in 2023
Blackshark.ai specializes in creating a 3D digital twin of Earth by utilizing satellite imagery to automatically extract and reconstruct detailed attributes in photorealistic 3D. The company's platform employs a scalable artificial intelligence system that accurately detects global features with remarkable precision and speed. Its patented 3D reconstruction methodology can store vast amounts of data while rendering it in real-time, supporting various applications including geospatial intelligence, humanitarian aid, urban planning, and autonomous vehicle navigation. Blackshark.ai serves a diverse clientele worldwide and operates with a team of over 100 professionals in Silicon Valley and Graz, Austria, which is recognized as a hub for computer vision technology. The platform’s capabilities facilitate efficient analysis in mapping, navigation, and earth observation, making it a valuable resource for businesses and governmental organizations.

DataLoop

Series B in 2022
DataLoop is an Israeli company founded in 2017, specializing in artificial intelligence products and solutions for data automation. Based in Herzliya, the company focuses on streamlining the preparation of visual data for machine and deep learning applications. Its data management and annotation platform facilitates the creation and deployment of computer vision pipelines, encompassing data labeling, automated data operations, and the integration of human oversight for data validation. By addressing various data challenges, DataLoop enables organizations to enhance their operational efficiency and concentrate on their core business activities while reducing costs associated with data preparation.

Taranis

Series D in 2022
Taranis is an agriculture intelligence company that has developed an advanced platform utilizing computer vision, data science, and deep learning algorithms to monitor fields effectively. Its solution provides high-precision aerial surveillance imagery, enabling farmers to detect early signs of issues such as weeds, nutrient deficiencies, crop disease, insect infestations, and water damage. By offering accurate insights, Taranis helps agribusinesses make informed decisions that can prevent crop yield loss and ultimately enhance productivity.

NeuReality

Series A in 2022
NeuReality is a semiconductor start-up focused on creating AI-as-a-service infrastructure to meet the demands of AI deployment across cloud, edge, and fog systems. The company specializes in purpose-built AI-centric architecture, offering a server-on-chip solution that reconfigures inference technologies like computer vision, natural language processing, and recommendation engines. This innovative approach simplifies the implementation of these technologies for companies that may lack extensive technical expertise. By replacing traditional CPU-centric models with its advanced architecture, NeuReality enables clients to reduce both costs and energy consumption, making AI more accessible and efficient for a broader range of users.

Scopio Labs

Series C in 2022
Scopio Labs Ltd., founded in 2015 and based in Tel Aviv, Israel, specializes in the development of advanced digital microscopes that utilize computational imaging technology. The company focuses on enhancing hematology diagnostics by providing tools that allow for high-resolution imaging of blood samples and bone marrow aspirates. Scopio Labs' solutions aim to improve the efficiency and accuracy of diagnosing blood-related diseases by enabling laboratories to analyze cell morphology at scale. Their offerings cater to various applications, including cancer screening, cytology, academic research, and drug discovery, thus unlocking actionable insights from complex datasets in clinical settings.

Hailo

Series C in 2021
Hailo Technologies Ltd. specializes in developing advanced AI processors that facilitate deep learning applications on edge devices. Founded in 2017 and based in Tel Aviv, Israel, the company has created products such as the Hailo-8 and Hail SDK, which allow devices to perform complex tasks like object detection, image enhancement, and real-time content creation while minimizing power consumption and cost. Hailo's processors are designed to integrate seamlessly into a wide range of smart devices, including those used in automotive, security, personal computing, and industrial automation sectors. By rethinking traditional computer architecture, Hailo enables edge devices to process data locally, enhancing their capabilities and operational efficiency.

Zippin

Series B in 2021
Zippin is a company based in the United States that specializes in AI-driven, checkout-free technology aimed at enhancing the retail shopping experience. It offers a platform that allows retailers to implement frictionless shopping solutions, eliminating the need for checkout lines and self-scanners. Utilizing advanced technologies such as deep learning-based computer vision and real-time sensor fusion, Zippin's system tracks products and shoppers through overhead cameras and smart shelf sensors, ensuring high accuracy even in crowded environments. Founded by industry experts with extensive backgrounds in retail technology and artificial intelligence, Zippin has secured venture funding from notable investors. The company is headquartered in San Francisco and focuses on transforming how consumers shop by allowing them to enter stores, select items, and leave without traditional checkout processes.

Kryon

Series D in 2021
Kryon specializes in Robotic Process Automation (RPA) solutions that drive digital transformation for enterprises. The company’s platform employs patented visual and deep learning technologies to automate business processes efficiently, leading to immediate productivity gains, minimal error rates, and significant cost savings. Kryon's RPA platform supports both unattended and attended automation, allowing seamless interaction between virtual and human workforces. This flexibility enhances the return on investment from automation efforts while fostering overall business process improvement. Numerous Fortune 500 companies utilize Kryon's solutions to achieve considerable efficiencies and reduce operational errors, thereby optimizing their workflows and enhancing customer experiences.

NeuReality

Seed Round in 2021
NeuReality is a semiconductor start-up focused on creating AI-as-a-service infrastructure to meet the demands of AI deployment across cloud, edge, and fog systems. The company specializes in purpose-built AI-centric architecture, offering a server-on-chip solution that reconfigures inference technologies like computer vision, natural language processing, and recommendation engines. This innovative approach simplifies the implementation of these technologies for companies that may lack extensive technical expertise. By replacing traditional CPU-centric models with its advanced architecture, NeuReality enables clients to reduce both costs and energy consumption, making AI more accessible and efficient for a broader range of users.

NeuReality

Seed Round in 2020
NeuReality is a semiconductor start-up focused on creating AI-as-a-service infrastructure to meet the demands of AI deployment across cloud, edge, and fog systems. The company specializes in purpose-built AI-centric architecture, offering a server-on-chip solution that reconfigures inference technologies like computer vision, natural language processing, and recommendation engines. This innovative approach simplifies the implementation of these technologies for companies that may lack extensive technical expertise. By replacing traditional CPU-centric models with its advanced architecture, NeuReality enables clients to reduce both costs and energy consumption, making AI more accessible and efficient for a broader range of users.

RideVision

Series A in 2020
RideVision is a technology company focused on enhancing motorcycle safety through its innovative Collision Aversion Technology (CAT™). This system utilizes computer vision and neural networks to detect, predict, and alert riders to potential road threats. By leveraging standard hardware and cameras, RideVision's technology delivers warning signals within milliseconds, significantly improving the safety and riding experience for motorcyclists. The system is designed to be compatible with a wide range of motorcycles, whether new or used, making advanced safety features accessible to a diverse audience of riders.

Tevel

Series C in 2020
Tevel is a company focused on addressing the significant shortage of agricultural labor by developing Flying Autonomous Robots™ designed for fruit picking. Founded in 2017 by Yaniv Maor, Tevel's robots utilize advanced artificial intelligence and computer vision to efficiently harvest fruit while minimizing damage. These agile robots can operate continuously, offering a cost-effective solution for farmers. Tevel's innovative software provides real-time monitoring of the harvesting process, allowing farmers to gain valuable insights into the quality and characteristics of the harvested fruit. This data aids growers in making informed decisions about market value and output. Tevel's headquarters are located in Israel, with additional branches in Italy and the United States.

DataLoop

Series A in 2020
DataLoop is an Israeli company founded in 2017, specializing in artificial intelligence products and solutions for data automation. Based in Herzliya, the company focuses on streamlining the preparation of visual data for machine and deep learning applications. Its data management and annotation platform facilitates the creation and deployment of computer vision pipelines, encompassing data labeling, automated data operations, and the integration of human oversight for data validation. By addressing various data challenges, DataLoop enables organizations to enhance their operational efficiency and concentrate on their core business activities while reducing costs associated with data preparation.

Sight Diagnostics

Series D in 2020
Sight Diagnostics Ltd. is a medical device company based in Tel Aviv, Israel, focused on advancing blood diagnostics through the integration of machine vision and artificial intelligence. The company has developed a platform that utilizes digital fluorescent microscopy and computer vision algorithms to diagnose various blood diseases. Its flagship product, Parasight, is designed for malaria detection and has been used in nearly one million tests across 24 countries, although it is not available for sale in the United States. Additionally, Sight Diagnostics has introduced the Sight OLO, a blood analyzer that requires only two drops of blood from a finger prick or venous sample to deliver lab-grade Complete Blood Count results within minutes. With a presence in the UK, the US, and Israel, Sight Diagnostics is expanding its commercial footprint across five continents, aiming to enhance healthcare through fast and accurate blood testing solutions.

Taranis

Series C in 2020
Taranis is an agriculture intelligence company that has developed an advanced platform utilizing computer vision, data science, and deep learning algorithms to monitor fields effectively. Its solution provides high-precision aerial surveillance imagery, enabling farmers to detect early signs of issues such as weeds, nutrient deficiencies, crop disease, insect infestations, and water damage. By offering accurate insights, Taranis helps agribusinesses make informed decisions that can prevent crop yield loss and ultimately enhance productivity.

Scopio Labs

Series B in 2020
Scopio Labs Ltd., founded in 2015 and based in Tel Aviv, Israel, specializes in the development of advanced digital microscopes that utilize computational imaging technology. The company focuses on enhancing hematology diagnostics by providing tools that allow for high-resolution imaging of blood samples and bone marrow aspirates. Scopio Labs' solutions aim to improve the efficiency and accuracy of diagnosing blood-related diseases by enabling laboratories to analyze cell morphology at scale. Their offerings cater to various applications, including cancer screening, cytology, academic research, and drug discovery, thus unlocking actionable insights from complex datasets in clinical settings.

Hailo

Series B in 2020
Hailo Technologies Ltd. specializes in developing advanced AI processors that facilitate deep learning applications on edge devices. Founded in 2017 and based in Tel Aviv, Israel, the company has created products such as the Hailo-8 and Hail SDK, which allow devices to perform complex tasks like object detection, image enhancement, and real-time content creation while minimizing power consumption and cost. Hailo's processors are designed to integrate seamlessly into a wide range of smart devices, including those used in automotive, security, personal computing, and industrial automation sectors. By rethinking traditional computer architecture, Hailo enables edge devices to process data locally, enhancing their capabilities and operational efficiency.

AutoBrains

Series B in 2019
AutoBrains is a developer of a visual intelligence platform designed to enhance the safety and effectiveness of autonomous driving services. The platform leverages advanced artificial intelligence, employing signature-based representation structures and unsupervised learning methodologies to create a detailed understanding of the vehicle's surroundings. This technology supports various applications, including advanced driver assistance systems and vehicle localization, ultimately aiming to improve car safety and reduce casualties on global roadways. With a foundation of over 200 patents, AutoBrains' self-learning technology represents a significant advancement in automotive visual intelligence.

Tevel

Series B in 2019
Tevel is a company focused on addressing the significant shortage of agricultural labor by developing Flying Autonomous Robots™ designed for fruit picking. Founded in 2017 by Yaniv Maor, Tevel's robots utilize advanced artificial intelligence and computer vision to efficiently harvest fruit while minimizing damage. These agile robots can operate continuously, offering a cost-effective solution for farmers. Tevel's innovative software provides real-time monitoring of the harvesting process, allowing farmers to gain valuable insights into the quality and characteristics of the harvested fruit. This data aids growers in making informed decisions about market value and output. Tevel's headquarters are located in Israel, with additional branches in Italy and the United States.

Brodmann17

Series A in 2019
Brodmann17 Ltd, founded in 2016 and headquartered in Hod Hasharon, Israel, specializes in developing advanced computer vision technology aimed at enhancing safety in mobility. The company's innovative AI solutions focus on pedestrian and face detection, among other applications, and are designed to operate efficiently on small devices. Utilizing deep learning neural networks, Brodmann17's software can extract comprehensive information from video feeds, significantly improving automated driving systems while optimizing performance and cost. Its patented, scalable perception software is hardware-agnostic, allowing for seamless integration across various platforms, from low-power edge devices to cloud systems. The company has garnered attention from prominent players in the technology and automotive sectors and is supported by various venture capital firms as well as major industry names.

Kryon

Series C in 2019
Kryon specializes in Robotic Process Automation (RPA) solutions that drive digital transformation for enterprises. The company’s platform employs patented visual and deep learning technologies to automate business processes efficiently, leading to immediate productivity gains, minimal error rates, and significant cost savings. Kryon's RPA platform supports both unattended and attended automation, allowing seamless interaction between virtual and human workforces. This flexibility enhances the return on investment from automation efforts while fostering overall business process improvement. Numerous Fortune 500 companies utilize Kryon's solutions to achieve considerable efficiencies and reduce operational errors, thereby optimizing their workflows and enhancing customer experiences.

Sight Diagnostics

Series C in 2019
Sight Diagnostics Ltd. is a medical device company based in Tel Aviv, Israel, focused on advancing blood diagnostics through the integration of machine vision and artificial intelligence. The company has developed a platform that utilizes digital fluorescent microscopy and computer vision algorithms to diagnose various blood diseases. Its flagship product, Parasight, is designed for malaria detection and has been used in nearly one million tests across 24 countries, although it is not available for sale in the United States. Additionally, Sight Diagnostics has introduced the Sight OLO, a blood analyzer that requires only two drops of blood from a finger prick or venous sample to deliver lab-grade Complete Blood Count results within minutes. With a presence in the UK, the US, and Israel, Sight Diagnostics is expanding its commercial footprint across five continents, aiming to enhance healthcare through fast and accurate blood testing solutions.

Hailo

Series A in 2019
Hailo Technologies Ltd. specializes in developing advanced AI processors that facilitate deep learning applications on edge devices. Founded in 2017 and based in Tel Aviv, Israel, the company has created products such as the Hailo-8 and Hail SDK, which allow devices to perform complex tasks like object detection, image enhancement, and real-time content creation while minimizing power consumption and cost. Hailo's processors are designed to integrate seamlessly into a wide range of smart devices, including those used in automotive, security, personal computing, and industrial automation sectors. By rethinking traditional computer architecture, Hailo enables edge devices to process data locally, enhancing their capabilities and operational efficiency.

Taranis

Series B in 2018
Taranis is an agriculture intelligence company that has developed an advanced platform utilizing computer vision, data science, and deep learning algorithms to monitor fields effectively. Its solution provides high-precision aerial surveillance imagery, enabling farmers to detect early signs of issues such as weeds, nutrient deficiencies, crop disease, insect infestations, and water damage. By offering accurate insights, Taranis helps agribusinesses make informed decisions that can prevent crop yield loss and ultimately enhance productivity.

VAYAVISION

Seed Round in 2018
VayaVision Sensing Ltd. is a technology company that specializes in developing perception engine software aimed at enhancing the safety and efficiency of autonomous driving. Founded in 2016 and headquartered in Or Yehuda, Israel, the company offers VAYA-Drive, an artificial intelligence cognition platform that integrates raw data fusion with advanced computer vision techniques. This platform generates comprehensive environmental models, enabling critical functions such as road and free space detection, lane detection, object detection and tracking, and recognition of traffic signs. By utilizing deep learning algorithms, VayaVision delivers a reliable detection and classification system that accurately assesses the size, shape, and velocity of surrounding objects, including small obstacles. This innovative approach not only improves sensing capabilities for autonomous vehicles but also contributes to cost reductions within the automotive industry. Since July 2020, VayaVision has operated as a subsidiary of LeddarTech Inc.

Zebra Medical Vision

Venture Round in 2018
Zebra Medical Vision Ltd. is a company that develops an imaging analytics platform aimed at enhancing patient care in healthcare institutions. Founded in 2014 and based in Shefayim, Israel, the platform utilizes advanced learning and computer vision algorithms to assist clinicians in identifying patients at risk of various diseases. This technology supports healthcare providers in implementing effective risk management and preventative care strategies. Zebra Medical Vision also supplies tools and datasets for machine-learning researchers, facilitating the rapid development of decision support tools and diagnostic solutions. The company has established strategic partnerships with organizations such as USARAD Holdings and TELUS Ventures, and has secured a total of $52 million in funding from notable investors, including Khosla Ventures and Nvidia. Its AI-driven products are FDA cleared and are utilized in hospitals across multiple regions, including the U.S., Europe, Australia, India, and Latin America, positioning Zebra Medical Vision as a leader in the field of medical imaging and analytics.

Zebra Medical Vision

Series C in 2018
Zebra Medical Vision Ltd. is a company that develops an imaging analytics platform aimed at enhancing patient care in healthcare institutions. Founded in 2014 and based in Shefayim, Israel, the platform utilizes advanced learning and computer vision algorithms to assist clinicians in identifying patients at risk of various diseases. This technology supports healthcare providers in implementing effective risk management and preventative care strategies. Zebra Medical Vision also supplies tools and datasets for machine-learning researchers, facilitating the rapid development of decision support tools and diagnostic solutions. The company has established strategic partnerships with organizations such as USARAD Holdings and TELUS Ventures, and has secured a total of $52 million in funding from notable investors, including Khosla Ventures and Nvidia. Its AI-driven products are FDA cleared and are utilized in hospitals across multiple regions, including the U.S., Europe, Australia, India, and Latin America, positioning Zebra Medical Vision as a leader in the field of medical imaging and analytics.

Hailo

Series A in 2018
Hailo Technologies Ltd. specializes in developing advanced AI processors that facilitate deep learning applications on edge devices. Founded in 2017 and based in Tel Aviv, Israel, the company has created products such as the Hailo-8 and Hail SDK, which allow devices to perform complex tasks like object detection, image enhancement, and real-time content creation while minimizing power consumption and cost. Hailo's processors are designed to integrate seamlessly into a wide range of smart devices, including those used in automotive, security, personal computing, and industrial automation sectors. By rethinking traditional computer architecture, Hailo enables edge devices to process data locally, enhancing their capabilities and operational efficiency.

Unispectral

Series A in 2018
Unispectral Ltd., founded in 2016 and headquartered in Tel Aviv, Israel, specializes in developing advanced camera sensors that leverage hyperspectral imaging technology. The company utilizes MEMS technology to distinguish the material properties of solids, liquids, and gases, enhancing traditional imaging with spectral data. Unispectral's platform captures megapixel images enriched with spectral information, allowing for improved object recognition and image processing. This innovation enables users to achieve significant enhancements in photography, particularly under low light and challenging lighting conditions, by combining deep learning techniques with spectral analysis.

Innoviz Technologies

Series B in 2017
Innoviz Technologies Ltd. specializes in designing and manufacturing solid-state LiDAR sensors and perception software that facilitate the mass production of autonomous vehicles. The company offers InnovizPro, a solid-state LiDAR known for its exceptional performance and value, and InnovizOne, an automotive-grade LiDAR sensor that delivers advanced 3D sensing capabilities for various levels of autonomous driving (Levels 3 to 5). Innoviz's products also include solutions for object identification and tracking, sensor fusion, as well as mapping and localization. The company partners with a range of notable investors and strategic allies, enhancing its position in the industry. Founded in 2016 and headquartered in Rosh HaAyin, Israel, Innoviz Technologies aims to provide comprehensive solutions for original equipment manufacturers (OEMs) and Tier-1 suppliers involved in the development of autonomous vehicles, serving markets that include passenger cars, robotaxis, shuttles, delivery vehicles, and logistics.

Scopio Labs

Venture Round in 2017
Scopio Labs Ltd., founded in 2015 and based in Tel Aviv, Israel, specializes in the development of advanced digital microscopes that utilize computational imaging technology. The company focuses on enhancing hematology diagnostics by providing tools that allow for high-resolution imaging of blood samples and bone marrow aspirates. Scopio Labs' solutions aim to improve the efficiency and accuracy of diagnosing blood-related diseases by enabling laboratories to analyze cell morphology at scale. Their offerings cater to various applications, including cancer screening, cytology, academic research, and drug discovery, thus unlocking actionable insights from complex datasets in clinical settings.

Taranis

Series A in 2017
Taranis is an agriculture intelligence company that has developed an advanced platform utilizing computer vision, data science, and deep learning algorithms to monitor fields effectively. Its solution provides high-precision aerial surveillance imagery, enabling farmers to detect early signs of issues such as weeds, nutrient deficiencies, crop disease, insect infestations, and water damage. By offering accurate insights, Taranis helps agribusinesses make informed decisions that can prevent crop yield loss and ultimately enhance productivity.

Sight Diagnostics

Series B in 2016
Sight Diagnostics Ltd. is a medical device company based in Tel Aviv, Israel, focused on advancing blood diagnostics through the integration of machine vision and artificial intelligence. The company has developed a platform that utilizes digital fluorescent microscopy and computer vision algorithms to diagnose various blood diseases. Its flagship product, Parasight, is designed for malaria detection and has been used in nearly one million tests across 24 countries, although it is not available for sale in the United States. Additionally, Sight Diagnostics has introduced the Sight OLO, a blood analyzer that requires only two drops of blood from a finger prick or venous sample to deliver lab-grade Complete Blood Count results within minutes. With a presence in the UK, the US, and Israel, Sight Diagnostics is expanding its commercial footprint across five continents, aiming to enhance healthcare through fast and accurate blood testing solutions.

Zebra Medical Vision

Series B in 2016
Zebra Medical Vision Ltd. is a company that develops an imaging analytics platform aimed at enhancing patient care in healthcare institutions. Founded in 2014 and based in Shefayim, Israel, the platform utilizes advanced learning and computer vision algorithms to assist clinicians in identifying patients at risk of various diseases. This technology supports healthcare providers in implementing effective risk management and preventative care strategies. Zebra Medical Vision also supplies tools and datasets for machine-learning researchers, facilitating the rapid development of decision support tools and diagnostic solutions. The company has established strategic partnerships with organizations such as USARAD Holdings and TELUS Ventures, and has secured a total of $52 million in funding from notable investors, including Khosla Ventures and Nvidia. Its AI-driven products are FDA cleared and are utilized in hospitals across multiple regions, including the U.S., Europe, Australia, India, and Latin America, positioning Zebra Medical Vision as a leader in the field of medical imaging and analytics.

Taranis

Seed Round in 2016
Taranis is an agriculture intelligence company that has developed an advanced platform utilizing computer vision, data science, and deep learning algorithms to monitor fields effectively. Its solution provides high-precision aerial surveillance imagery, enabling farmers to detect early signs of issues such as weeds, nutrient deficiencies, crop disease, insect infestations, and water damage. By offering accurate insights, Taranis helps agribusinesses make informed decisions that can prevent crop yield loss and ultimately enhance productivity.

Zebra Medical Vision

Series A in 2015
Zebra Medical Vision Ltd. is a company that develops an imaging analytics platform aimed at enhancing patient care in healthcare institutions. Founded in 2014 and based in Shefayim, Israel, the platform utilizes advanced learning and computer vision algorithms to assist clinicians in identifying patients at risk of various diseases. This technology supports healthcare providers in implementing effective risk management and preventative care strategies. Zebra Medical Vision also supplies tools and datasets for machine-learning researchers, facilitating the rapid development of decision support tools and diagnostic solutions. The company has established strategic partnerships with organizations such as USARAD Holdings and TELUS Ventures, and has secured a total of $52 million in funding from notable investors, including Khosla Ventures and Nvidia. Its AI-driven products are FDA cleared and are utilized in hospitals across multiple regions, including the U.S., Europe, Australia, India, and Latin America, positioning Zebra Medical Vision as a leader in the field of medical imaging and analytics.

Replay Technologies

Series B in 2015
Replay Technologies Inc. specializes in three-dimensional reconstruction technology for broadcasting events, including sports, news, and film. The company is known for its Free Dimensional Video (FreeD) technology, which enables the creation of dynamic viewing angles using high-speed camera sensors. Its product offerings include the SOLO freeD System, designed to allow users to hover around the action and capture views from any angle within a 180-degree coverage area, and the ARENA freeD System, which features 4K high-resolution capture capabilities for 360-degree coverage. Founded in 2011 and headquartered in Newark, California, Replay Technologies operates as a subsidiary of Intel Corporation.

MST Medical Surgery Technologies

Series C in 2015
MST Medical Surgery Technologies Ltd. develops innovative image analysis software aimed at enhancing surgical procedures in the healthcare sector. Founded in 2005 by entrepreneurs Ziv Tamir and Moti Sholev, the company is headquartered in Tel Aviv, Israel, with an additional office in Apollo Beach, Florida. MST's flagship product, AutoLap, is a robotic image-guided laparoscope positioning system that utilizes advanced image analysis technology to provide surgeons with real-time control during operations, ensuring an optimal field of view. Additionally, the company offers Surgical Training Analytics (STA), a tool designed to capture and analyze images from actual surgeries performed by trainee surgeons. By leveraging artificial intelligence, machine learning, and data analytics, MST aims to empower and automate the surgical environment, thereby improving outcomes for surgeons, healthcare providers, and patients alike.

Zebra Medical Vision

Seed Round in 2015
Zebra Medical Vision Ltd. is a company that develops an imaging analytics platform aimed at enhancing patient care in healthcare institutions. Founded in 2014 and based in Shefayim, Israel, the platform utilizes advanced learning and computer vision algorithms to assist clinicians in identifying patients at risk of various diseases. This technology supports healthcare providers in implementing effective risk management and preventative care strategies. Zebra Medical Vision also supplies tools and datasets for machine-learning researchers, facilitating the rapid development of decision support tools and diagnostic solutions. The company has established strategic partnerships with organizations such as USARAD Holdings and TELUS Ventures, and has secured a total of $52 million in funding from notable investors, including Khosla Ventures and Nvidia. Its AI-driven products are FDA cleared and are utilized in hospitals across multiple regions, including the U.S., Europe, Australia, India, and Latin America, positioning Zebra Medical Vision as a leader in the field of medical imaging and analytics.

Corephotonics

Series B in 2015
Corephotonics Ltd. specializes in developing dual camera technologies for mobile devices, aiming to enhance mobile photography. Founded in 2012 and based in Tel Aviv-Yafo, Israel, the company offers a range of innovative products, including the Hummingbird camera, which features continuous optical zoom and advanced video capabilities, and the Falcon camera with enhanced autofocus for quicker focus adjustments. Additionally, the Hawkeye camera incorporates optical image stabilization to improve indoor photography by reducing motion blur. Corephotonics also provides dual aperture cameras for improved low-light performance and digital bokeh effects, along with software solutions that enhance low-light and optical zoom capabilities. By collaborating closely with manufacturers from early design stages, Corephotonics ensures its technologies meet specific imaging requirements, facilitating seamless integration into mass production. The company is recognized as a leader in the dual camera market, focusing on delivering high-quality imaging solutions in compact formats.

Sight Diagnostics

Series A in 2014
Sight Diagnostics Ltd. is a medical device company based in Tel Aviv, Israel, focused on advancing blood diagnostics through the integration of machine vision and artificial intelligence. The company has developed a platform that utilizes digital fluorescent microscopy and computer vision algorithms to diagnose various blood diseases. Its flagship product, Parasight, is designed for malaria detection and has been used in nearly one million tests across 24 countries, although it is not available for sale in the United States. Additionally, Sight Diagnostics has introduced the Sight OLO, a blood analyzer that requires only two drops of blood from a finger prick or venous sample to deliver lab-grade Complete Blood Count results within minutes. With a presence in the UK, the US, and Israel, Sight Diagnostics is expanding its commercial footprint across five continents, aiming to enhance healthcare through fast and accurate blood testing solutions.

MST Medical Surgery Technologies

Series B in 2014
MST Medical Surgery Technologies Ltd. develops innovative image analysis software aimed at enhancing surgical procedures in the healthcare sector. Founded in 2005 by entrepreneurs Ziv Tamir and Moti Sholev, the company is headquartered in Tel Aviv, Israel, with an additional office in Apollo Beach, Florida. MST's flagship product, AutoLap, is a robotic image-guided laparoscope positioning system that utilizes advanced image analysis technology to provide surgeons with real-time control during operations, ensuring an optimal field of view. Additionally, the company offers Surgical Training Analytics (STA), a tool designed to capture and analyze images from actual surgeries performed by trainee surgeons. By leveraging artificial intelligence, machine learning, and data analytics, MST aims to empower and automate the surgical environment, thereby improving outcomes for surgeons, healthcare providers, and patients alike.

Sight Diagnostics

Seed Round in 2011
Sight Diagnostics Ltd. is a medical device company based in Tel Aviv, Israel, focused on advancing blood diagnostics through the integration of machine vision and artificial intelligence. The company has developed a platform that utilizes digital fluorescent microscopy and computer vision algorithms to diagnose various blood diseases. Its flagship product, Parasight, is designed for malaria detection and has been used in nearly one million tests across 24 countries, although it is not available for sale in the United States. Additionally, Sight Diagnostics has introduced the Sight OLO, a blood analyzer that requires only two drops of blood from a finger prick or venous sample to deliver lab-grade Complete Blood Count results within minutes. With a presence in the UK, the US, and Israel, Sight Diagnostics is expanding its commercial footprint across five continents, aiming to enhance healthcare through fast and accurate blood testing solutions.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.